Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.exer.2021.108908

PubMed Identifier: 34954204

Publication URI: http://europepmc.org/abstract/MED/34954204

Type: Journal Article/Review

Parent Publication: Experimental Eye Research

ISSN: 0014-4835